Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Ciccolini

Showing results (81-90 of 168) with videos related to

Pageof 17
Sort By:
Pharmacology Research & Perspectives|March 21, 2021
Unraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncologyEtienne Chatelut, Jeroen J M A Hendrikx, Jennifer Martin, et al.
Fundamental & Clinical Pharmacology|January 3, 2025
Body mass index affects imatinib exposure: Real-world evidence from TDM with adaptive dosingPaul Maroselli, Raphaelle Fanciullino, Julien Colle, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 21, 2019
Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non-Small Cell Lung CancerBenjamin K Schneider, Arnaud Boyer, Joseph Ciccolini, et al.
Therapeutic Drug Monitoring|November 27, 2002
Population pharmacokinetics of etoposide: application to therapeutic drug monitoringJoseph Ciccolini, Suzanne Monjanel-Mouterde, Sok-Siya Bun, et al.
Cancer Chemotherapy and Pharmacology|August 2, 2014
Metronomics chemotherapy: time for computational decision supportDominique Barbolosi, Joseph Ciccolini, Christophe Meille, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic CancerAnnalisa Comandatore, Benoit Immordino, Rita Balsano, et al.
Pharmacogenetics and Genomics|July 9, 2014
Recipient/donor contradictory genotypes with impact on drug pharmacogenetics after liver transplant: a deadly gift?Cindy Serdjebi, Joseph Ciccolini, Frederic Fina, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 16, 2018
Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?Arnaud Boyer, Eddy Pasquier, Pascale Tomasini, et al.
Pharmacogenomics|January 23, 2020
Pharmacogenetics and pharmacokinetics modeling of unexpected and extremely severe toxicities after sorafenib intakeHai le Ba, Litaty Mbatchi, Florence Gattacceca, et al.
Clinical Pharmacokinetics|March 1, 2019
Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint InhibitorsMaddalena Centanni, Dirk Jan A R Moes, Iñaki F Trocóniz, et al.
Pageof 17

Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
Pharmacology Research & Perspectives|March 21, 2021
Unraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncologyEtienne Chatelut, Jeroen J M A Hendrikx, Jennifer Martin, et al.
Fundamental & Clinical Pharmacology|January 3, 2025
Body mass index affects imatinib exposure: Real-world evidence from TDM with adaptive dosingPaul Maroselli, Raphaelle Fanciullino, Julien Colle, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 21, 2019
Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non-Small Cell Lung CancerBenjamin K Schneider, Arnaud Boyer, Joseph Ciccolini, et al.
Therapeutic Drug Monitoring|November 27, 2002
Population pharmacokinetics of etoposide: application to therapeutic drug monitoringJoseph Ciccolini, Suzanne Monjanel-Mouterde, Sok-Siya Bun, et al.
Cancer Chemotherapy and Pharmacology|August 2, 2014
Metronomics chemotherapy: time for computational decision supportDominique Barbolosi, Joseph Ciccolini, Christophe Meille, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic CancerAnnalisa Comandatore, Benoit Immordino, Rita Balsano, et al.
Pharmacogenetics and Genomics|July 9, 2014
Recipient/donor contradictory genotypes with impact on drug pharmacogenetics after liver transplant: a deadly gift?Cindy Serdjebi, Joseph Ciccolini, Frederic Fina, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 16, 2018
Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?Arnaud Boyer, Eddy Pasquier, Pascale Tomasini, et al.
Pharmacogenomics|January 23, 2020
Pharmacogenetics and pharmacokinetics modeling of unexpected and extremely severe toxicities after sorafenib intakeHai le Ba, Litaty Mbatchi, Florence Gattacceca, et al.
Clinical Pharmacokinetics|March 1, 2019
Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint InhibitorsMaddalena Centanni, Dirk Jan A R Moes, Iñaki F Trocóniz, et al.
Pageof 17